Science News for
International Stroke Conference 2016

Nursing Symposium: Feb. 16, 2016
Pre-Con Symposia: Feb. 16, 2016
Sessions: Feb. 17-19, 2016
Los Angeles Convention Center | Los Angeles, Calif.

Welcome to Science News for 2016

SCIENCE NEWS for #ISC16 features interviews, presenter slides, and exclusive summaries you won't see anywhere else.


ISC 2016 Videos

ISC 2016 Video Playlist

Kyra Becker, MD, Bruce Ovbiagele, MD, and Colin Derdeyn, MD provide an overview of the science that was presented for ISC 2016 in Los Angeles.


More Resources


Selected Science from Wednesday, February 17

Acute Endovascular Treatment Oral Abstracts I
  • Thrace Study: Final Results
Plenary Session I
  • Main Results of the Insulin Resistance Intervention After Stroke (IRIS) Trial
  • Finding Atrial Fibrillation In Stroke Patients - A Multicenter Randomised Evaluation Of Enhanced And Prolonged Holter Monitoring (Find-AFrandomised- Trial)
  • Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis: Initial and Five-year Results of the ACT 1 Trial
  • ARTSS-2: Final Results of a Pilot, Phase IIb, Randomized, Multi-center Trial of Argatroban in Combination With Recombinant Tissue Plasminogen Activator for Acute Stroke
Late Breaking Science - Oral Abstracts I
  • ICTuS-2 Final Results
  • High-dose Statin Therapy After Acute Ischemic Stroke: The Phase 2 Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART)
  • GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia
  • Time is Brain in Endovascular Thrombectomy: Results From Individual Patient Pooled Data Analysis of Mr Clean, Escape, Extend IA, Swift Prime and Revascat
  • Virtual Reality in Stroke Rehabilitation: Results From EVREST Multicenter Trial
  • Results of the Pragmatic Ischaemic Thrombectomy Evaluation (PISTE) Trial

Selected Science from Thursday, February 18

Plenary Session II
  • Carotid Endarterectomy versus Stenting for Treatment of Carotid Artery Stenosis: Long-term Results of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST)
  • A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA): 5-year Results
  • Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III) Results
  • Efficiency of Intraventricular Hemorrhage Removal Determines Modified Rankin Scale Score (CLEAR III)
  • Randomized Trial on Normalization of International Normalized Ratio Using Prothrombin Complex or Fresh Frozen Plasma in Vitamin-k Related Intracranial Bleeding
Late Breaking Science Oral Abstracts II
  • Predictors of Intracranial Hemorrhage and Clinical Outcome After Stentriever Thrombectomy: Pooled Analysis From Swift Prime, Swift and Star Trials
  • Randomized Trial of Revascularization with Solitaire FR® dDevice versus Best Medical Therapy in the Treatment of Acute Stroke due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset) REVASCAT Trial- Final Results at 12 Months
  • Expanding Opportunities for Intravenous Alteplase Treatment of Patients With Unwitnessed Acute Stroke Using MRI-based Patient Selection: Imaging Results of the MR WITNESS Multicenter Trial
  • Endovascular Treatment in Acute Ischemic Stroke: A Meta-analysis of Individual Patient Data From Mr Clean, Escape, Extend IA, Swift Prime and Revascat
  • MultiStem® Treatment Reduces Length of Hospitalization When Administered Within 36 Hours After Onset of Ischemic Stroke: Implications on Lowering Stroke Related Health Care Costs
  • Validation of a Simplified Eight-item NIHSS to Identify Acute Ischemic Stroke Patients With Large Vessel Occlusion
  • Cost-effectiveness of Solitaire + IV-tPA for Acute Ischemic Stroke: Results From the Swift-Prime Trial

Selected Science from Friday, February 19

Plenary Session III
  • Primary Results of the ACTION Trial of Natalizumab in Acute Ischemic Stroke (AIS)
  • IV Alteplase in MR-selected Patients With Stroke of Unknown Onset is Safe and Feasible: Results of the Multicenter MR WITNESS Trial
  • GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis as Proof-of-Concept